Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
This paper reports results of the DIA-DA observation program designed to study the efficacy and safety of the DPP-4 inhibitor sitagliptin added tometformin therapy in different regions of the Russian Federation. The study included 923 patients with DM2 (mean duration 4.5 years) uncontrolledby diet a...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5489 |
| _version_ | 1797255286823583744 |
|---|---|
| author | Marina Vladimirovna Shestakova |
| author_facet | Marina Vladimirovna Shestakova |
| author_sort | Marina Vladimirovna Shestakova |
| collection | DOAJ |
| description | This paper reports results of the DIA-DA observation program designed to study the efficacy and safety of the DPP-4 inhibitor sitagliptin added tometformin therapy in different regions of the Russian Federation. The study included 923 patients with DM2 (mean duration 4.5 years) uncontrolledby diet and metformin monotherapy. They were transferred to the combined treatment with sitagliptin and metformin during 6 months. The mainend-points assessed in the study were hypoglycemic efficiency, frequency of side-effects, and satisfaction of patients and physicians with the treatment.The target HbA1c level |
| first_indexed | 2024-03-08T15:22:28Z |
| format | Article |
| id | doaj.art-885e51dbaa8b4003872f07898896a2a0 |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2024-04-24T22:03:27Z |
| publishDate | 2010-09-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-885e51dbaa8b4003872f07898896a2a02024-03-20T11:47:56ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782010-09-01133576010.14341/2072-0351-54895447Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation programMarina Vladimirovna Shestakova0Endocrinological Research Centre, MoscowThis paper reports results of the DIA-DA observation program designed to study the efficacy and safety of the DPP-4 inhibitor sitagliptin added tometformin therapy in different regions of the Russian Federation. The study included 923 patients with DM2 (mean duration 4.5 years) uncontrolledby diet and metformin monotherapy. They were transferred to the combined treatment with sitagliptin and metformin during 6 months. The mainend-points assessed in the study were hypoglycemic efficiency, frequency of side-effects, and satisfaction of patients and physicians with the treatment.The target HbA1c levelhttps://www.dia-endojournals.ru/jour/article/view/5489type 2 diabetes mellitusdpp-4 inhibitorsitagliptinmetformin |
| spellingShingle | Marina Vladimirovna Shestakova Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program Сахарный диабет type 2 diabetes mellitus dpp-4 inhibitor sitagliptin metformin |
| title | Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program |
| title_full | Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program |
| title_fullStr | Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program |
| title_full_unstemmed | Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program |
| title_short | Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program |
| title_sort | experience with sitagliptin the first dpp 4 inhibitor application to the treatment of type 2 diabetes mellitus in the russian federation results of the dia da observation program |
| topic | type 2 diabetes mellitus dpp-4 inhibitor sitagliptin metformin |
| url | https://www.dia-endojournals.ru/jour/article/view/5489 |
| work_keys_str_mv | AT marinavladimirovnashestakova experiencewithsitagliptinthefirstdpp4inhibitorapplicationtothetreatmentoftype2diabetesmellitusintherussianfederationresultsofthediadaobservationprogram |